Enzyme replacement therapy (ERT) with Cerezyme (imiglucerase) in children with Gaucher disease type 3 (GD3) led to marked and quick improvement…
Shelly Rae Rich
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.